IMA Q1 2023 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$67M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+57.0% YoY

Gross Profit

$5M100.0% margin

Operating Income

-$16M-292.0% margin

Net Income

-$14M-267.6% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

-2.5%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$152M

Total Liabilities

$17M

Stockholders' Equity

$135M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$3M	+57.0%
Gross Profit	$5M	-$11M	+148.5%
Operating Income	-$16M	-$17M	+8.5%
Net Income	-$14M	-$17M	+15.6%